LifeTech Scientific Corporation submitted its Monthly Return for July 2026 to Hong Kong Exchanges and Clearing on 4 August 2026, confirming that no changes occurred in its authorised or issued share capital during the period.

Authorised Capital • Authorised share capital remained at 40.00 billion ordinary shares with a par value of USD 0.00000125 each, equivalent to USD 50,000.

Issued Shares and Public Float • Issued ordinary shares stood unchanged at 4.63 billion. • The company held no treasury shares, and it affirmed compliance with the HKEX minimum public-float threshold of 25 percent.

Equity Incentive Schemes • Two share-option schemes together accounted for 308.24 million outstanding options (25.29 million under Scheme 1; 282.95 million under Scheme 2). • No options were exercised in July, leaving the issued-share count unchanged. • Shares that could still be issued on option exercise total 140.58 million, while a further 151.38 million options remain available for future grant under Scheme 2.

Other Securities • The company reported no warrants, convertible securities or other equity arrangements, and there were no repurchases or redemptions.

The absence of share movements in July indicates stable capital structure, with LifeTech Sci continuing to satisfy all regulatory requirements for listing on the Main Board of the Hong Kong Stock Exchange.